Hemo Organic has informed that the meeting of the Board of Directors of the Company is scheduled on 14/02/2019, to consider and approve and take on record the Unaudited Financial Result of the Company for the quarter and nine months ended on December 31, 2018 as per Regulation 33 of the Listing Regulation; and consider and discuss any other items as may be decided by the Board of Directors of the Company.
The above information is a part of company’s filings submitted to BSE.